Charles Schwab Investment Management Inc Ovid Therapeutics Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 161,808 shares of OVID stock, worth $153,717. This represents 0.0% of its overall portfolio holdings.

Number of Shares
161,808
Previous 161,808 -0.0%
Holding current value
$153,717
Previous $124,000 53.23%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024
SELL
$2.98 - $3.78 $24,519 - $31,101
-8,228 Reduced 4.84%
161,808 $521,000
Q3 2023

Nov 08, 2023
BUY
$3.23 - $3.97 $23,866 - $29,334
7,389 Added 4.54%
170,036 $652,000
Q2 2023

Aug 09, 2023
BUY
$2.53 - $3.89 $321,332 - $494,065
127,009 Added 356.39%
162,647 $533,000
Q1 2023

May 11, 2023
BUY
$1.88 - $2.85 $30,429 - $46,130
16,186 Added 83.21%
35,638 $91,000
Q2 2021

Aug 16, 2021
SELL
$3.3 - $4.49 $327,775 - $445,973
-99,326 Reduced 83.62%
19,452 $77,000
Q1 2021

May 17, 2021
BUY
$2.42 - $4.47 $26,368 - $48,705
10,896 Added 10.1%
118,778 $478,000
Q4 2020

Feb 16, 2021
BUY
$2.28 - $6.84 $23,810 - $71,430
10,443 Added 10.72%
107,882 $250,000
Q3 2020

Nov 13, 2020
SELL
$5.39 - $8.24 $18,390 - $28,114
-3,412 Reduced 3.38%
97,439 $560,000
Q2 2020

Aug 14, 2020
BUY
$2.67 - $7.91 $219,668 - $650,779
82,273 Added 442.85%
100,851 $744,000
Q4 2019

Feb 07, 2020
BUY
$2.08 - $5.06 $38,642 - $94,004
18,578 New
18,578 $78,000
Q3 2019

Nov 08, 2019
SELL
$1.76 - $3.51 $128,883 - $257,033
-73,229 Closed
0 $0
Q2 2019

Aug 09, 2019
SELL
$1.59 - $2.14 $43,516 - $58,569
-27,369 Reduced 27.21%
73,229 $136,000
Q1 2019

May 14, 2019
BUY
$1.77 - $3.56 $74,564 - $149,972
42,127 Added 72.05%
100,598 $179,000
Q4 2018

Feb 14, 2019
SELL
$2.42 - $6.6 $2,942 - $8,025
-1,216 Reduced 2.04%
58,471 $142,000
Q3 2018

Nov 13, 2018
BUY
$5.6 - $11.0 $138,583 - $272,217
24,747 Added 70.83%
59,687 $339,000
Q2 2018

Aug 08, 2018
BUY
$6.16 - $10.14 $3,973 - $6,540
645 Added 1.88%
34,940 $273,000
Q1 2018

May 07, 2018
BUY
$6.53 - $9.82 $90,016 - $135,368
13,785 Added 67.21%
34,295 $243,000
Q4 2017

Jan 17, 2018
BUY
$6.12 - $12.31 $36,781 - $73,983
6,010 Added 41.45%
20,510 $203,000
Q3 2017

Nov 13, 2017
BUY
$5.32 - $9.77 $77,140 - $141,665
14,500
14,500 $125,000

Others Institutions Holding OVID

# of Institutions
75
Shares Held
39M
Call Options Held
37.4K
Put Options Held
500
View Full List

About Ovid Therapeutics Inc.

OVID Quotes by TradingView
  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $66.9M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email